A randomized, placebo-controlled trial (NCIC CTG MAP1) examining the effects of letrozole on mammographic breast density and other end organs in postmenopausal women

Mammographic Density and the Risk and Detection of Breast Cancer

Norman F. Boyd, Helen Guo, Lisa J. Martin et al. · New England Journal of Medicine · 2007 · 2.5K citations · Full text

Medicine, Oncology, Radiology +14

Quantitative Classification of Mammographic Densities and Breast Cancer Risk: Results From the Canadian National Breast Screening Study

Norman F. Boyd, J W Byng, Roberta A. Jong et al. · JNCI Journal of the National Cancer Institute · 1995 · 1.1K citations

Medicine, Oncology, Radiology +16

Mammographic Features and Breast Cancer Risk: Effects With Time, Age, and Menopause Status

Celia Byrne, Catherine Schairer, J. Wolfe et al. · JNCI Journal of the National Cancer Institute · 1995 · 868 citations

Medicine, Endocrinology, Radiology +16

The quantitative analysis of mammographic densities

J W Byng, Norman F. Boyd, E Fishell et al. · Physics in Medicine and Biology · 1994 · 615 citations

Medicine, Oncology, Radiology +17

Quantitative Assessment of Mammographic Breast Density: Relationship with Breast Cancer Risk

Jennifer A. Harvey · Radiology · 2004 · 491 citations

Medicine, Endocrinology, Oncology +17